Cargando…
A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis
Ipilimumab, a novel therapy for metastatic melanoma, inhibits cytotoxic T-lymphocyte apoptosis, causing both antitumor activity and significant autoimmunity, including autoimmune thyroiditis. Steroids are frequently used in treatment of immune-related adverse events; however, a concern regarding the...
Autores principales: | Yu, Christine, Chopra, Inder J, Ha, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330494/ https://www.ncbi.nlm.nih.gov/pubmed/25759760 http://dx.doi.org/10.1530/EDM-14-0092 |
Ejemplares similares
-
Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies
por: Gunawan, Florence, et al.
Publicado: (2018) -
High-dose intravenous hydrocortisone for the treatment of hyperthyroidism: a rare precipitant of thyrotoxicosis periodic paralysis
por: Scheive, Melanie, et al.
Publicado: (2023) -
Presentation of new onset type 1 diabetes with diabetic ketoacidosis and hyperosmolar hyperglycaemia after a single dose of nivolumab and ipilimumab
por: Stathi, Dimitra, et al.
Publicado: (2023) -
A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment
por: Tufton, Nicola, et al.
Publicado: (2015) -
A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma
por: Hakami, Osamah A, et al.
Publicado: (2019)